bullish
Olympus--Dead Money for Momentum Investors; Dip-Buying Time for Long-Term Investors
258 Views31 May 2017 11:22
Olympus generates 98% of its profits from endoscopes sales and has a 70% global share of gastro enteral endoscope systems. Their current line-up is...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Olympus Placement: Small Deal Size, Positive Sentiment, and Good Track Record01 Dec 2017
- Olympus (7733)--Why the Offering Is a Long-Term Buying Opportunity27 Nov 2017
- Olympus (7733) US$450mm Secondary Offering26 Nov 2017
- Olympus--Dead Money for Momentum Investors; Dip-Buying Time for Long-Term Investors31 May 2017
x